Swiss Life Sciences Stock News

SWX:AMS
SWX:AMSSemiconductor

Ams-OSRAM (SWX:AMS) Margin Slide Deepens Q1 Loss And Tests Bullish Valuation Narrative

ams-OSRAM (SWX:AMS) has opened 2026 with Q1 revenue of €796 million and a basic EPS loss of €1.57, alongside a net income loss of €155 million, putting fresh numbers behind a story that already had investors watching closely. Over recent quarters the company has seen revenue move between €775 million and €881 million, while quarterly EPS has ranged from a small €0.01 profit to losses of €0.83. This gives you a clear view of how top line stability contrasts with pressure on the bottom line...
SWX:SCMN
SWX:SCMNTelecom

Swisscom (SWX:SCMN) Margin Compression Sparks Debate After Q1 2026 Earnings

Q1 2026 earnings snapshot Swisscom (SWX:SCMN) kicked off 2026 with Q1 revenue of CHF3.6b and basic EPS of CHF6.41, alongside net income of CHF332m, providing an early indication of how the year is starting to develop. Over recent quarters, revenue has moved between CHF2.9b in Q4 2024 and CHF3.9b in Q4 2025, while quarterly EPS has ranged from about CHF5.00 to CHF7.08, giving investors a view of how the top and bottom lines have been tracking ahead of this latest report. With trailing net...
SWX:ALC
SWX:ALCMedical Equipment

A Look At Alcon (SWX:ALC) Valuation After Earnings Miss And New US$1.5b Buyback

Earnings miss, weaker profit, and new buyback sharpen focus on Alcon stock Alcon (SWX:ALC) reported first quarter 2026 revenue growth supported by recent product launches and market share gains. Profit came under pressure, guidance was reaffirmed, and a US$1.5b share repurchase plan was introduced. See our latest analysis for Alcon. Alcon's latest earnings and the new US$1.5b buyback have coincided with a sharp reset in sentiment, with a 7 day share price return of a 13.6% decline and a 1...
SWX:NOVN
SWX:NOVNPharmaceuticals

Assessing Novartis (SWX:NOVN) Valuation After Rhapsido Approval And US Manufacturing Expansion

Novartis (SWX:NOVN) just picked up European Commission approval for Rhapsido, a first in class oral treatment for chronic spontaneous urticaria, while also committing substantial US manufacturing and research spending on advanced therapies. See our latest analysis for Novartis. Recent news around Rhapsido approval and expanded US manufacturing sits against a share price of CHF115.64, with a 1 year total shareholder return of 29.77% and a 5 year total shareholder return of 83.35%. This...
SWX:BUCN
SWX:BUCNMachinery

Bucher Industries (SWX:BUCN) Valuation After 2026 Guidance For Stable Sales And Operating Margins

Bucher Industries (SWX:BUCN) has drawn fresh attention after issuing 2026 guidance, signalling expectations for stable sales and an operating margin in line with last year, while highlighting political uncertainty around demand recovery. See our latest analysis for Bucher Industries. The share price has reacted positively to the new 2026 guidance in the very short term, with a 1 day share price return of 2.24% and a 7 day share price return of 4.25%. However, this comes against a weaker...
SWX:LOGN
SWX:LOGNTech

Assessing Whether Logitech International (SWX:LOGN) Still Looks Undervalued After Recent Share Price Momentum

Why Logitech International (SWX:LOGN) is on investors’ radar today Logitech International (SWX:LOGN) has drawn interest after recent price moves, including a 1 day return of about a 0.4% decline and gains of roughly 3.6% over the past week and 8.9% over the past month. See our latest analysis for Logitech International. Looking beyond the latest move, Logitech’s 15.1% 90 day share price return and 27.8% 1 year total shareholder return point to momentum that contrasts with a relatively flat...
SWX:LMN
SWX:LMNHospitality

Lastminute.com (SWX:LMN) Q1 EPS Holds At €0.62 Testing Profitability Narratives

lastminute.com (SWX:LMN) has kicked off Q1 2026 with revenue of €96.4 million and basic EPS of €0.62, setting the tone for how its travel platform is translating demand into earnings. The company has seen quarterly revenue move from €89.2 million and EPS of €0.61 in Q1 2025 to €96.4 million and EPS of €0.62 in the latest quarter, while trailing 12 month EPS sits at €1.10 on revenue of €368.5 million. This leaves investors focused on how effectively those revenues are flowing through to...
SWX:HOLN
SWX:HOLNBasic Materials

Holcim (SWX:HOLN) Valuation Check After Fossil Free Cement Breakthrough With Fully Electrified Clinker Production

Holcim (SWX:HOLN) is back in focus after partner SaltX Technology produced Portland-quality cement clinker using a fully electrified process, confirming a proof of concept for fossil-free cement production ahead of a planned pilot plant. See our latest analysis for Holcim. Holcim's latest electrification breakthrough comes as the stock trades at CHF74.1, with a 10.27% 1 month share price return but a 5.17% year to date share price decline. The 5 year total shareholder return of 216.06% points...
SWX:ALC
SWX:ALCMedical Equipment

Alcon (SWX:ALC) Margin Compression Challenges Bullish Earnings Growth Narratives

Alcon (SWX:ALC) opened 2026 with Q1 revenue of US$2.7b and basic EPS of US$0.39, setting a clear marker for how the year is starting after a period where trailing 12 month revenue sat at US$10.6b and EPS at US$1.67. Over recent quarters, the company has seen revenue move from US$2.5b in Q4 2024 to around US$2.7b in Q1 2026, while quarterly EPS has ranged from US$0.36 to US$0.71. This gives investors a wide set of earnings outcomes to weigh against a reported trailing net margin of 7.7% and...
SWX:NOVN
SWX:NOVNPharmaceuticals

Is It Too Late To Consider Novartis (SWX:NOVN) After Its 3 Year 41.9% Rise?

Investors may be wondering if Novartis at CHF113.54 is still offering value, or if most of the easy gains are already on the table. The stock is up 25.9% over the last year and 41.9% over 3 years, even though it shows a 1% decline over 7 days, a 7.8% decline over 30 days, and a 4.6% return year to date. Recent headlines have focused on Novartis as a large global pharmaceutical business, with investors watching how its product portfolio and pipeline shape long term expectations. This context...
SWX:TEMN
SWX:TEMNSoftware

Temenos Wins Global SaaS Deals As Cloud Strategy And Valuation Attract Attention

Temenos (SWX:TEMN) has secured new SaaS core banking agreements with First Abu Dhabi Bank in Saudi Arabia and Questrade in Canada. The company is expanding its SaaS offering on Amazon Web Services to cover end to end digital banking and payments. These updates relate to Temenos' cloud banking platform and its global client reach across the Middle East and North America. For Temenos, a provider of core banking and digital banking software, these wins highlight how large banks and non bank...
SWX:UBSG
SWX:UBSGCapital Markets

Swiss Capital Reforms Put UBS Group Growth And Shareholder Returns In Focus

Swiss lawmakers are advancing reforms that could impose major new capital requirements on UBS Group's Swiss unit following the Credit Suisse acquisition. The proposed rules aim to reshape UBS's regulatory obligations and risk profile in Switzerland. This legislative process is ongoing and could have a direct impact on UBS's future capital structure and profitability. For investors watching SWX:UBSG, this comes at a time when the stock trades at around CHF34.56 and has delivered a 39.5%...
SWX:BANB
SWX:BANBLife Sciences

A Look At Bachem Holding (SWX:BANB) Valuation After Chief Commercial Officer Departure News

Bachem Holding (SWX:BANB) is back in focus after announcing the departure of Chief Commercial Officer Torsten Wöhr. CEO Anne-Kathrin Stoller is set to temporarily assume commercial responsibilities from May 25, 2026. See our latest analysis for Bachem Holding. The leadership change comes as Bachem Holding’s share price trades at CHF75.45, with a 7 day share price return of 10.71% and a year to date share price return of 29.08%. The 1 year total shareholder return of 54.39% contrasts with a 3...
SWX:ACLN
SWX:ACLNElectrical

A Look At Accelleron Industries (SWX:ACLN) Valuation After Approval Of A Higher 2025 Dividend

Dividend decision and board changes put Accelleron Industries (SWX:ACLN) in focus Accelleron Industries (SWX:ACLN) drew investor attention after shareholders approved a higher CHF 1.50 per share dividend for the 2025 financial year at the 2026 Annual General Meeting. See our latest analysis for Accelleron Industries. Alongside the higher dividend and board refresh, Accelleron Industries’ CHF85.35 share price sits after a 34.62% year to date share price return and a very strong 3 year total...
SWX:SGSN
SWX:SGSNProfessional Services

Did SGS’s Q1 2026 Update Quietly Reframe Its Long-Term Story for (SWX:SGSN) Investors?

In April 2026, SGS SA held its Q1 2026 sales and trading statement call, providing investors with an update on recent operating trends and management’s latest commentary on the business. This routine update appears to have meaningfully influenced investor sentiment, highlighting how even scheduled disclosures about trading conditions and outlook can reshape perceptions of SGS’s longer-term prospects. We’ll now consider how the Q1 2026 trading update, and any shifts in management commentary...
SWX:LAND
SWX:LANDElectronic

A Look At Landis+Gyr Group (SWX:LAND) Valuation After Joining EPRI’s Open Power AI Consortium

Landis+Gyr Group (SWX:LAND) has joined EPRI’s Open Power AI Consortium, a collaboration focused on open-source AI and GenAI tools for electric utilities tackling reliability, efficiency, and customer service challenges. See our latest analysis for Landis+Gyr Group. At a share price of CHF53.0, Landis+Gyr’s recent 1 day share price return of 1.15% and 30 day share price return of 3.92% sit against a softer 3 year total shareholder return of 28.59% decline. This suggests recent momentum has...
SWX:TEMN
SWX:TEMNSoftware

A Look At Temenos (SWX:TEMN) Valuation After Q1 Growth And New CFO Appointment

Temenos (SWX:TEMN) has just paired a first quarter earnings update with a change in its finance leadership, providing fresh information on both its recent financial performance and how the company is organizing for future execution. See our latest analysis for Temenos. At a share price of CHF75.0, the stock has recovered from a softer start to the year, with a 90 day share price return of 16.64% and a 1 year total shareholder return of 27.33%. This suggests that recent momentum has been...
SWX:IDIA
SWX:IDIABiotechs

Idorsia (SWX:IDIA) Valuation Check After QUVIVIQ Guidance And First Quarter 2026 Update

What Idorsia’s new QUVIVIQ guidance tells you Idorsia (SWX:IDIA) has put QUVIVIQ at the center of its 2026 outlook, guiding for CHF 200 million in sales after releasing its first quarter results and updating progress on its broader pipeline and partnerships. See our latest analysis for Idorsia. Following the first quarter update and QUVIVIQ guidance, Idorsia’s recent share price moves look mixed, with a 30 day share price return of 8.16% but a year to date share price return of a 6.35%...
SWX:ROP
SWX:ROPPharmaceuticals

Roche Holding (SWX:ROP) Valuation Check After Recent Share Price Weakness And Pullback

Roche Holding stock: recent move puts long term returns in context Roche Holding (SWX:ROP) has drawn attention after a recent pullback, with the stock down about 0.6% over the past day and just over 1% over the past week. For readers tracking longer horizons, the share price shows a small decline over the past month and a larger negative move over the past 3 months, while multi year total returns remain positive. See our latest analysis for Roche Holding. At a share price of CHF316.5, Roche...
SWX:OERL
SWX:OERLMachinery

OC Oerlikon (SWX:OERL) Valuation Check After Sector-Driven Share Price Move And Earnings Anticipation

OC Oerlikon (SWX:OERL) rose 4.13% on April 30, 2026, on heavier trading within the industrial machinery sector, as some investors appeared to reposition before the company’s August 6 earnings announcement. See our latest analysis for OC Oerlikon. That 4.43% 1 day share price return and 5.24% 7 day gain come after a weaker 90 day share price return of 8.45%, while the 1 year total shareholder return of 30.25% contrasts with losses over three and five years. This suggests short term momentum...
SWX:APGN
SWX:APGNMedia

Undiscovered European Gems to Explore This May 2026

As the European market navigates a complex landscape marked by flat performance in the STOXX Europe 600 Index and cautious sentiment due to geopolitical tensions and rising oil prices, investors are increasingly on the lookout for opportunities within small-cap stocks that might offer untapped potential. In this environment, a good stock is often characterized by strong fundamentals, resilience in earnings growth despite broader economic challenges, and strategic positioning that can...
SWX:SCHN
SWX:SCHNMachinery

A Look At Schindler (SWX:SCHN) Valuation After Mixed First Quarter 2026 Results

Schindler Holding (SWX:SCHN) has drawn fresh attention after reporting first quarter 2026 results, with sales of CHF 2,593 million, net income of CHF 262 million and basic EPS from continuing operations of CHF 2.34. See our latest analysis for Schindler Holding. The first quarter update, with lower sales but slightly higher net income and EPS, comes after a 4.59% 1 month share price return. The year to date share price return of 8.07% and 1 year total shareholder return of 5.53% indicate...